Bigdon, E.;                     Steinhorst, N.A.;                     Weissleder, S.;                     Durchkiv, V.;                     Stübiger, N.    
        Treatment in Latent Tuberculosis Uveitis—Is Immunosuppression Effective or Is Conventional 3- or 4-Drug Antituberculosis Therapy Mandatory? J. Clin. Med. 2022, 11, 2419.
    https://doi.org/10.3390/jcm11092419
    AMA Style
    
                                Bigdon E,                                 Steinhorst NA,                                 Weissleder S,                                 Durchkiv V,                                 Stübiger N.        
                Treatment in Latent Tuberculosis Uveitis—Is Immunosuppression Effective or Is Conventional 3- or 4-Drug Antituberculosis Therapy Mandatory? Journal of Clinical Medicine. 2022; 11(9):2419.
        https://doi.org/10.3390/jcm11092419
    
    Chicago/Turabian Style
    
                                Bigdon, Eileen,                                 Nils Alexander Steinhorst,                                 Stephanie Weissleder,                                 Vasyl Durchkiv,                                 and Nicole Stübiger.        
                2022. "Treatment in Latent Tuberculosis Uveitis—Is Immunosuppression Effective or Is Conventional 3- or 4-Drug Antituberculosis Therapy Mandatory?" Journal of Clinical Medicine 11, no. 9: 2419.
        https://doi.org/10.3390/jcm11092419
    
    APA Style
    
                                Bigdon, E.,                                 Steinhorst, N. A.,                                 Weissleder, S.,                                 Durchkiv, V.,                                 & Stübiger, N.        
        
        (2022). Treatment in Latent Tuberculosis Uveitis—Is Immunosuppression Effective or Is Conventional 3- or 4-Drug Antituberculosis Therapy Mandatory? Journal of Clinical Medicine, 11(9), 2419.
        https://doi.org/10.3390/jcm11092419